Arcturus Therapeutics Holdings Inc. has grown revenue −52% a year over three years and 28% a year over five. Revenue growth, 3-year annual rate: −52% (Biotechnology median +17%). Revenue growth, 5-year rate: +28%, growth has slowed since the five-year average. Years of annual history on file: 8, FY2018 to FY2025, as filed.

ARCTArcturus Therapeutics Holdings Inc.

Healthcare

$6.82-49% 1Y

$6.82

$5.5252 weeks$23.16

Is it growing?

Watch

Growth is fading: revenue shrinking (−76% year on year) and operating margin narrowing (−631.9 points).

2 to watch, 1 without data

Revenue trend−76% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +28% a year.

Margin direction−631.9 points operating

Trailing-twelve-month operating margin, -699.6% now against -67.7% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is ARCT growing?

Arcturus Therapeutics Holdings Inc. has grown revenue −52% a year over three years and 28% a year over five.

−52%

Revenue growth, 3-year annual rate · Biotechnology median +17% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +28%
Revenue growth, 5-year rate · −52% over three · growth has slowed since the five-year average
Years of annual history on file: 8
Years of annual history on file · FY2018 to FY2025, as filed

Details›